It’s a day in the life of a Broadway pharmacy, the one where people come in, grab a pill and head to the cash register.

It’s not the kind of scene that makes headlines.

The line for the pharmacy’s first pharmacy shift was less than 10 minutes long and the line-ups stretched well beyond the parking lot.

It was the same at the other end of the street, where the line for a new pharmacy was about three minutes long.

But the pharmacy at 8th and Broad is one of the few places in the country where it is now.

Last month, the pharmacy that had been the subject of an investigation by the FDA for its use of “unapproved drugs” moved from its old location on Broadway to its new one, the same location where the pharmacy used to be.

It was one of many developments at the intersection of Broadway and Madison that came about as a result of the state’s “open marketplace” for prescription drugs, which allows patients to shop for the medicines they need, without being forced to go through a pharmacy chain or paying a higher price.

At least half of the country’s pharmacies have closed since the federal government passed the Affordable Care Act, which created the open market.

Many of those closures have been due to concerns over higher prescription drug prices.

The open market is designed to make it easier for Americans to buy and shop for prescription medications, and it has the added benefit of allowing the government to help small pharmacies compete for scarce supplies.

Since the open marketplace began, states have opened more than 1.2 million pharmacies, or about one-quarter of the U.S. market, and about a third of them have been set up to serve the uninsured.

But it’s not just the cost of prescription drugs that has led to the closures.

It also has driven some pharmacies to seek to outsource their work to private firms, where they can lower their prices and hire more workers.

The federal government has invested more than $1 billion in prescription drug companies over the past two decades.

The pharmaceutical industry has spent $5 billion to support a dozen or so small businesses that have sprung up in the past year to help supply pharmacies, according to the drug industry trade group Pharmaceutical Research and Manufacturers of America.

Pharmaceutical companies have taken on an outsized role in the opening of the open markets, with some saying that the government should let them help set prices and to provide financing to the private companies that are providing those drugs.

“When you have a big, well-known company like Turing or Novartis in the marketplace, and they’re making billions, the private sector doesn’t really want to compete with them,” said Dan O’Neil, vice president of government affairs for the American Pharmacists Association.

“They want to do their own thing.”

Pharma companies also have come under pressure to cut costs by outsourcing their work, said Scott Sperling, vice chairman of the New York State Public Health Department.

“The government is taking away competition and giving the private industry an advantage that the public is not going to like,” he said.

“It’s the same as the public trying to go out and buy a car or an airplane.”

The open market has also brought a new type of competition into the marketplace.

The competition to fill prescriptions in the open, private markets has been fierce.

Pharmacies are required to dispense drugs at a set price, and pharmacies have to provide a drug-delivery service and provide discounts to patients.

While some of those competitors have had success, they have faced resistance.

In a sign of how competitive the industry has become, a drug called Nexium was recently pulled from the market in New Jersey after an FDA investigation found that it contained a type of drug that was being sold by a competitor without a prescription from the federal drug agency.

Even though the federal agency is in the midst of an open-market investigation into the company, the agency did not require a license to buy or sell the drug, according a statement released by the U-M Health system in which the pharmacy was based.

That prompted a petition to Congress that called on the agency to revoke the license for the company that is selling the drug.

As more and more pharmacies have opened, some have opened in more rural areas, where people may not have access to prescription drugs.

They are also opening in places where they have been closed, such as in rural Alabama, where more than 100 stores have opened since the open-markets began.

The number of pharmacies opened in those areas rose from about 150 in 2014 to more than 500 in 2016, according.

For a pharmacy like the one at 8-8-8, which is the only one in the city of Arlington, it has been a difficult transition.

A few of the pharmacy workers have stayed on.

The store has been open only six weeks,